AnnJi Advances AJ201 into Phase 3 Trial for Kennedy’s Disease

AJ201 (rosolutamide) is an investigational oral small molecule designed to address multiple disease mechanisms of spinal and bulbar muscular atrophy (SBM...

October 06, 2026 | Tuesday | News
Everest Medicines Advances Local Manufacturing of VELSIPITY in China with Priority Review

Everest Medicines recently announced that the Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) has accepte...

October 05, 2026 | Monday | News
Tandem Diabetes Care Expands Tandem Mobi Automated Insulin Delivery to 12 Global Markets

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, announced that Tandem Mobi, the world’s smalle...

September 29, 2026 | Tuesday | News
Sun Nuclear Validates AdaptCHECK for Siemens Healthineers’ Accela Adaptive Radiotherapy System

Sun Nuclear, a Mirion Medical company, announced that its AdaptCHECK™ software has been validated in collaboration with Siemens Healthineers technica...

September 29, 2026 | Tuesday | News
Grünenthal and DKSH Expand Asia-Pacific Partnership to Broaden Access to Pain Medicines

Grünenthal, a global leader in pain management and research, and DKSH Business Unit Healthcare, a strategic healthcare business partner and leading pr...

September 29, 2026 | Tuesday | News
Elixir Medical Secures Japan Approval for DynamX Sirolimus-Eluting Coronary Bioadaptor System

Elixir Medical (Milpitas, Calif., and Tokyo) announced that its DynamX® Sirolimus-Eluting Coronary Bioadaptor System for the treatment of cor...

September 16, 2026 | Wednesday | News
Basilea Partner Asahi Kasei Starts Phase 2 Cresemba Study in Children in Japan

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bac...

September 15, 2026 | Tuesday | News
Insilico Medicine Doses First Patient in Phase III Trial of AI-Discovered Rentosertib for IPF

Insilico Medicine ("Insilico," HKEX: 3696), a clinical-stage biotechnology company powered by generative AI, announced that it has dosed the first patien...

September 11, 2026 | Friday | News
GCCL Expands Asia-Pacific Clinical Trial Partnerships at ABP 2026

GCCL (Global Clinical Central Lab), a South Korea-based leading provider of clinical trial sample analysis, announced its participation as a Platinum Spo...

September 09, 2026 | Wednesday | News
Rezubio Advances RZ-520 Into Phase 1 Clinical Trial

Rezubio announced that it has successfully completed dosing of the first cohort in its Phase 1 clinical trial following clearances from the US FDA a...

September 08, 2026 | Tuesday | News
CelluPro Becomes First Chinese Cell Culture Media Supplier to Achieve EXCiPACT™ GMP Certification

CelluPro, a biotechnology company specializing in serum-free cell culture media and bioprocess solutions, has achieved EXCiPACT™ GMP Certifica...

September 08, 2026 | Tuesday | News
HUTCHMED Reports Positive Phase III SANOVO Results for ORPATHYS® Plus TAGRISSO® in First-Line EGFR-Mutated NSCLC

HUTCHMED (China) Limited announces positive high-level results from the SANOVO China Phase III trial in treatment-naïve patients with locally advanc...

September 01, 2026 | Tuesday | News
Roche Reports Positive Two-Year Vabysmo Data in Polypoidal Choroidal Vasculopathy

Roche announced new two-year data from the Phase IIIb/IV SALWEEN study of Vabysmo® (faricimab), presented at the 19th Asia-Pacific Vitreo-retina Soci...

August 31, 2026 | Monday | News
Perceptra Expands Thai Medical AI Across Asia With Launch of Inspectra MMG

Perceptra Co., Ltd., a Thai startup developing artificial intelligence technology for medical image analysis, has officially announced its entry into ...

August 27, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close